Võrdle meetodeid
Vaata valitud meetodeid kõrvuti; erinevad read on esile tõstetud.
| Menopausi hindamise skaala (MRS)× | Naiste seksuaalfunktsiooni indeks (FSFI)× | |
|---|---|---|
| Valdkond | Uroloogia ja günekoloogia | Uroloogia ja günekoloogia |
| Perekond | Process / pipeline | Process / pipeline |
| Tekkeaasta | 2000 | 2000 |
| Looja≠ | Heinemann et al. | Rosen et al. |
| Tüüp≠ | Self-report symptom scale | Self-report questionnaire |
| Algallikas≠ | Heinemann, K., Assmann, A., Möhner, S., & Schneider, H. P. (2004). The Menopause Rating Scale (MRS) as outcome measure for hormone replacement therapy. Menopause, 11(5), 571–578. DOI ↗ | Rosen, R., Brown, C., Heiman, J., Leiblum, S., Meston, C., Shabsigh, R., & D'Agostino, R. (2000). The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. Journal of Sex & Marital Therapy, 26(2), 191–208. DOI ↗ |
| Rööpnimetused | MRS | FSFI |
| Seotud≠ | 3 | 4 |
| Kokkuvõte≠ | The MRS is an 11-item self-report symptom scale designed to assess the frequency and severity of menopausal symptoms including vasomotor complaints, psychologic symptoms, and urogenital manifestations. Developed by Heinemann and colleagues in Germany and first published in 2000, it has become the most widely used symptom measure in menopause research and clinical practice across 60+ countries and languages. | The FSFI is a 19-item multidimensional self-report instrument designed to assess sexual function in women across the lifespan. Developed by Rosen and colleagues in 2000, it measures six core domains of sexual response and has become a gold standard in both clinical and research settings for evaluating female sexual dysfunction. |
| ScholarGateAndmestik ↗ |
|
|